TRYPTAMINE THERAPEUTICS
Tryptamine Therapeutics Limited is a clinical-stage biotechnology company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. Tryptamine Therapeutics intends to accomplish this through the development of an IV infusion of psilocin (the active metabolite of psilocybin) which addresses many of the current limitations associated with orally administered psilocybin used by the majority of competitors in the field. Tryp’s lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy.
TRYPTAMINE THERAPEUTICS
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Kelowna, British Columbia, Canada
Country:
Canada
Website Url:
http://www.tryptherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15.49 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro LetsEncrypt SSL By Default Font Awesome Mobile Non Scaleable Content Nginx Cloudflare JS CDN JS
Similar Organizations
Aclipse Therapeutics
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Asalyxa Bio
Asalyxa Bio is committed to developing neutrophil targeting treatments for diseases with a high unmet medical need.
Sapience Therapeutics
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Teclison
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Jason Carroll
Jason Carroll investment in Post-IPO Debt - Tryptamine Therapeutics
Marc Lustig
Marc Lustig investment in Post-IPO Equity - Tryptamine Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2023-08-03 | Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer |
| 2022-06-23 | Tryp Therapeutics Appoints New Chief Operating Officer |
Official Site Inspections
http://www.tryptherapeutics.com Semrush global rank: 10.48 M Semrush visits lastest month: 228
- Host name: syn05be.syd6.hostyourservices.net
- IP address: 110.232.143.82
- Location: Brisbane Australia
- Latitude: -27.4732
- Longitude: 153.0215
- Timezone: Australia/Brisbane
- Postal: 4000
More informations about "Tryptamine Therapeutics"
About Us - Tryptamine Therapeutics
Team Management Team Our leaders bring an enormous breadth and depth of proven experience in building companies in the pharmaceuticals sector. Jason Carroll Chief Executive Officer view more Hamish George Chief Financial …See details»
Tryp Therapeutics Inc. | The Canadian Securities Exchange (CSE)
For more information, please visit www.tryptherapeutics.com. Contacts. Phone 1-833-811-8797. Address c/o Pushor Mitchell LLP 301 - 1665 Ellis Street Kelowna, BC V1Y 2B3 CA. Transfer …See details»
Tryptamine Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Tryptamine Therapeutics Limited is a clinical-stage biotechnology company focused on bringing transformative medicine with known safety …See details»
Tryp Therapeutics - LinkedIn
Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat ...See details»
Tryp Therapeutics | Psychedelic Finance
For more information, please visit www.tryptherapeutics.com. Leadership Team The TRYP Management team has decades of experience building successful pharmaceutical and biotech companies together, and bring a balanced …See details»
Tryptamine Therapeutics - PitchBook
Tryptamine Therapeutics General Information Description. Operator of a clinical-stage biotechnology company focused on developing proprietary, novel formulations for administering psilocin in combination with psychotherapy to …See details»
Tryp Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 301 – 1665 Ellis Street . Kelowna, British Columbia, V1Y 2B3, Canada. 833-811-8797See details»
Tryptamine Therapeutics Home - Tryptamine …
Precision Psychedelic Therapy Pioneering a precision approach to psychedelics, targeting precise drug blood levels in patients Exploring innovative solutions in psychedelic drug development for enhanced patient care. Clinical-stage …See details»
Tryp Therapeutics Announces Significant Milestone in Its Clinical …
Jan 8, 2024 KELOWNA BC / ACCESSWIRE / January 8, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF), a pioneering clinical-stage biotechnology …See details»
Tryp Therapeutics - Craft
Tryp Therapeutics is a psychedelic drug development company that provides psilocybin-based compounds for the treatment of orphan diseases. It offers a psilocybin-for-neuropsychiatric …See details»
Tryp Therapeutics (TRYP) - Psychedelic Alpha
Oct 3, 2022 Tryp Therapeutics is a pharmaceutical company focused on identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet …See details»
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
May 26, 2021 www.tryptherapeutics.com. About Alcami. Alcami is a contract development and manufacturing organization headquartered in North Carolina with over 40 years of experience …See details»
Tryp Therapeutics - Overview, News & Similar companies
Apr 24, 2024 Tryp Therapeutics contact info: Phone number: (833) 811-8797 Website: www.tryptherapeutics.com What does Tryp Therapeutics do? Tryp Therapeutics is a …See details»
Corporate Governance Statement - Tryp Therapeutics
Hamilton Locke Corporate Governance Statement 1 3472-4059-7546, v. 2 hamiltonlocke.com.au Corporate Governance Statement Tryptamine Therapeutics Limited (Company) The Board of …See details»
Tryptamine Therapeutics Ltd. - Drug pipelines, Patents ... - Patsnap
Investor & Media Contact Peter Molloy Chief Business Officer Tryp Therapeutics Inc. [email protected] Forward-Looking Information Certain information in this news …See details»
Tryp Therapeutics Receives Confirmation from FDA to Proceed …
Dec 2, 2021 For more information, please visit www.tryptherapeutics.com. Investor Relations: Joseph Green Edison Group [email protected] Media Relations: Abby Berger KCSA Strategic …See details»
Tryp Therapeutics Announces Fiscal Year 2022 Financial Results …
Dec 13, 2022 Kelowna, British Columbia, Canada – (December 13, 2022) – Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on …See details»
Tryp Therapeutics Inc. Announces Signing Of Definitive Agreement …
Dec 13, 2023 KELOWNA, BC / ACCESSWIRE / December 11, 2023 / Tryp Therapeutics Inc. (“Tryp” or the “Company“) (CSE:TRYP), a clinical-stage biotechnology company focused on …See details»
Tryp Therapeutics Announces Advancement of Phase 2a Clinical …
Dec 23, 2021 For more information, please visit www.tryptherapeutics.com. Investor Inquiries: Joseph Green Edison Group [email protected] Media Inquiries: Abby Berger KCSA Strategic …See details»
Tryp Therapeutics Receives Confirmation From FDA To Proceed …
Jul 13, 2023 Tryp Therapeutics has received confirmation from the U.S. Food and Drug Administration that its review of Tryp’s Investigational New Drug #163,994 is complete and …See details»